Status:
ACTIVE_NOT_RECRUITING
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Cancer
Death
Eligibility:
All Genders
55-74 years
Brief Summary
The Division of Cancer Preventionl (DCP, formerly DCPC), under extramural contracts to 10 U.S. clinical centers, is evaluating the effectiveness of screening for prostate, lung, colorectal and ovarian...
Detailed Description
The Division of Cancer Preventionl (DCP, formerly DCPC), under extramural contracts to 10 U.S. clinical centers, is evaluating the effectiveness of screening for prostate, lung, colorectal and ovarian...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Men and women aged 55-74 years who do not have a prior history of PLCO tumors and have not undergone routine screening.
Exclusion
Key Trial Info
Start Date :
May 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
154900 Patients enrolled
Trial Details
Trial ID
NCT00339495
Start Date
May 1 1998
End Date
December 31 2025
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westat, Inc.
Rockville, Maryland, United States, 20850